(Date:12/1/2008)...ritis Foundation announces the 2008 winners of the.... The recipients, Dr. Gerard Karsenty of the Colum...l Nussenzweig of Rockefeller University received t... in the cure and control of rheumatic diseases. ,...the development and function of the skeletal syste...
(Date:12/1/2008)...-FirstCall/ -- Senetek PLC,(OTC Bulletin Board: S...elopment of technologies that target the science o...oup AG, specialists in the fields of strategic,de...ith offices in Zurich,Bern and Geneva has publis... Research Report, available in the "Investors" sec...
(Date:12/1/2008)...er (PTSD) affects as many as one in five of all Am...pe, assault, war or terrorism. It has emotionally ...s, families. , There is no broadly accepted tre... disorder, but thanks to a Tel Aviv University res... just around the corner. , Prof. Joseph Zohar fr...
(Date:12/1/2008)...rstCall/ -- SpectraScience, Inc.,(OTC Bulletin Bo...ny, today,announced that it has been awarded a Eu...issue Diagnosis. , Jim Hitchin, SpectraScience,...e Company,s optical biopsy technology because it p...lance, characterization, diagnosis and treatment. ...
Breaking Medicine News(10 mins):Health News:Easing the stress of trauma 2Health News:SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis 2(Date:12/1/2008)...led for Tuesday, December 9 at 11:00 am ET to Disc...UTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-Fi... SNSS ), a biopharmaceutical company focused on ...ogy therapeutics, today announced new data from it...AML) will be presented during the 50th American So...
(Date:11/28/2008)...vember 28 German biotech company,...alized HIV monitoring and,AIDS patient follow-up ... In,the year 2008, 2.5 million patient tests have...hly affordable "CyFlow" system, supporting already... Due to introduction of the,Partec innovation, th...
(Date:11/26/2008)...jects , , FRANKLIN, Mass., Nov. 26 /PRNewsw...oard: PLCSF) announced today that it has received ...ration (FDA) for its U.S. pivotal trial to study t...m(TM) and associated therapy in the prevention of...e FDA also approved PLC,s request to expand their ...
(Date:11/25/2008)...f., Nov. 25 Poniard,Pha...eutical company focused on,innovative oncology th...,strategic alternatives for its preclinical resea...us its resources on the clinical development of pi...ort the initial commercialization of,picoplatin i...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Arpida Presents Preclinical Data on AR 2474 at ICAAC 723 1Arpida Presents Preclinical Data on AR 2474 at ICAAC 723 2Arpida Presents Preclinical Data on AR 2474 at ICAAC 723 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 1Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 5One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 1One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 2One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 3One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 4One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 5One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 6One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 7Multiple corticosteroid injections in pregnant women may increase cerebral palsy 1712 1Multiple corticosteroid injections in pregnant women may increase cerebral palsy 1712 2...CH TRIANGLE PARK, N.C. & SHERBROOKE, Quebec--(...leading biopharmaceutical,company developing small...nal and metabolic diseases, today announced positi... in accelerating,gastric emptying in diabetic pati...se IIa study were presented at the American,Diabet...
...reece--(BUSINESS WIRE)--Jun 26, 2007 - Acceleron P...g therapeutics for the,treatment of musculoskeleta...nounced results demonstrating that ACE-011, a,nove...ss, preserved,bone mass and architecture in a muri...a malignancy of plasma cells in the bone marrow,th...
Other Medicine Technology:Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 2Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 3ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 2ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 3...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
... potent naturally occurring androgen produced from...a-reductase [1]. The concentrations of 5a-reducta...uding genital skin and hair follicles, and are loc...th the nuclear membrane. DHT exerts its biologica...
Medicine Products: